Aquinox Pharmaceuticals (AQXP) Announces Quarterly Earnings Results, Misses Estimates By $0.24 EPS
Aquinox Pharmaceuticals (NASDAQ:AQXP) released its earnings data on Tuesday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.24, American Banking & Market News reports.
Shares of Aquinox Pharmaceuticals (NASDAQ:AQXP) opened at 7.56 on Tuesday. Aquinox Pharmaceuticals has a 1-year low of $7.33 and a 1-year high of $14.35. The stock’s 50-day moving average is $8.40 and its 200-day moving average is $9.77. The company’s market cap is $80.7 million.
On the ratings front, analysts at Jefferies Group cut their price target on shares of Aquinox Pharmaceuticals from $17.00 to $16.00 in a research note on Tuesday.
Aquinox Pharmaceuticals, Inc is a clinical-stage pharmaceutical company discovering and developing drug candidates to treat inflammation and cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.